Pharmaceutical Sciences

Pharmaceutical Sciences Experts

H L Luessen

Pharmaceutical Science
Promethra biosciences


Henrik Luessen comes to Promethera as the Founder and Managing Director of Tytonis B.V., The Netherlands. At Promethera, Henrik serves as Chief Business Officer where he is responsible for identifying and executing strategic corporate development initiatives and licensing agreements. In the past, Henrik was involved in the foundation to trade sale of several life science firms such as Symbiotec GmbH, Nanomi BV and Activaero GmbH. He also served as Chief Business Officer at OctoPlus NV until its initial public offering in 2006. During his time at OctoPlus, Henrik commercially developed the company from a group of 12 employees with a core expertise in pharmaceutical development services of biopharmaceutical compounds to an organization of 140 people with two proprietary products in clinical development. During his career he has concluded around  250 IP-related, transactional and licensing deals. Henrik obtained his Ph.D. in Pharmaceutics and Biopharmaceutics from the Leiden/Amsterdam Center for Drug Research in 1996 and graduated at the University of Hamburg as Pharmacist in 1991.

Research Interest

Pharmaceutical Science 

Global Experts from Belgium

Global Experts in Subject

Share This Profile
Recommended Conferences
  • 6th European Biopharma Congress

    September 18-19, 2018 Amsterdam, Netherlands

  • 6th European Biopharma Congress

    September 18-19, 2018 Amsterdam, Netherlands

  • 5th International Conference on Pain Medicine and Pain Management

    October 17-18, 2018 New York, USA

  • 18th World Pharma Congress

    October 18-20, 2018 Warsaw, Poland

  • 13th International Conference on Biosimilars and Biologics

    November 14-15, 2018 Lisbon, Portugal

View more